Prediction of dysnatremias in critically ill patients based on the law of conservation of mass. Comparison of existing formulae

por Katsiampoura, Anastasia, Toumpanakis, Dimitrios, Konsta, Konstantina, Varkaris, Andreas, Vassilakopoulos, Theodoros
Publicado 2018

MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation

por Arai, Seiji, Varkaris, Andreas, Nouri, Mannan, Chen, Sen, Xie, Lisha, Balk, Steven P
Publicado 2020

Unusual Presentation of Hemophagocytic Lymphohistiocytosis in a Kidney Transplant Patient

por Yang, Danwen, Thamcharoen, Natanong, Marcus, Chelsea, Varkaris, Andreas, Aird, William, Khankin, Eliyahu V., Cardarelli, Francesca
Publicado 2019

Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?

por Sehgal, Kartik, Varkaris, Andreas, Viray, Hollis, VanderLaan, Paul A, Rangachari, Deepa, Costa, Daniel B
Publicado 2020

Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer

por Westaby, Daniel, Jimenez-Vacas, Juan M., Padilha, Ana, Varkaris, Andreas, Balk, Steven P., de Bono, Johann S., Sharp, Adam
Publicado 2021

EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors

por Vasconcelos, Pedro E.N.S., Gergis, Carol, Viray, Hollis, Varkaris, Andreas, Fujii, Masanori, Rangachari, Deepa, VanderLaan, Paul A., Kobayashi, Ikei S., Kobayashi, Susumu S., Costa, Daniel B.
Publicado 2020

Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways

por Dayyani, Farshid, Parikh, Nila U., Varkaris, Andreas S., Song, Jian H., Moorthy, Shhyam, Chatterji, Tanushree, Maity, Sankar N., Wolfe, Adam R., Carboni, Joan M., Gottardis, Marco M., Logothetis, Christopher J., Gallick, Gary E.
Publicado 2012

Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells

por Chatterji, Tanushree, Varkaris, Andreas S., Parikh, Nila U., Song, Jian H., Cheng, Chien-Jui, Schweppe, Rebecca E., Alexander, Stephanie, Davis, John W., Troncoso, Patricia, Friedl, Peter, Kuang, Jian, Lin, Sue-Hwa, Gallick, Gary E.
Publicado 2015

Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy

por Gaur, Sanchaika, Wen, Yunfei, Song, Jian H., Parikh, Nila U., Mangala, Lingegowda S., Blessing, Alicia M., Ivan, Cristina, Wu, Sherry Y., Varkaris, Andreas, Shi, Yan, Lopez-Berestein, Gabriel, Frigo, Daniel E., Sood, Anil K., Gallick, Gary E.
Publicado 2015

Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer

por Varkaris, Andreas, Katsiampoura, Anastasia, Davis, Jennifer S., Shah, Neeraj, Lam, Michael, Frias, Rosa Lizeth, Ivan, Cristina, Shimizu, Masayoshi, Morris, Jeffrey, Menter, David, Overman, Michael, Tran, Hai, Heymach, John, Chun, Yun Shin, Vauthey, Jean-Nicolas, Calin, George, Kopetz, Scott
Publicado 2019